This is not the most recent version of the article. View current version (31 JUL 2014)

Intervention Protocol

Addition of inhaled anticholinergics to beta2-agonists for children with acute asthma in hospital

  1. Kevin Vézina1,
  2. Bhupendrasinh F Chauhan2,
  3. Francine M Ducharme3,4,*

Editorial Group: Cochrane Airways Group

Published Online: 12 DEC 2012

DOI: 10.1002/14651858.CD010283


How to Cite

Vézina K, Chauhan BF, Ducharme FM. Addition of inhaled anticholinergics to beta2-agonists for children with acute asthma in hospital (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD010283. DOI: 10.1002/14651858.CD010283.

Author Information

  1. 1

    CHU Sainte-Justine, Department of Pediatrics, Montreal, Canada

  2. 2

    Research Centre, CHU Sainte-Justine, Clinical Research Unit on Childhood Asthma, Montreal, Canada

  3. 3

    University of Montreal, Department of Paediatrics, Montreal, Québec, Canada

  4. 4

    CHU Sainte-Justine, Research Centre, Montreal, Canada

*Francine M Ducharme, francine.m.ducharme@umontreal.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 12 DEC 2012

SEARCH

This is not the most recent version of the article. View current version (31 JUL 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy and safety of adding anticholinergics to β2-agonists as inhaled or nebulized therapy in children hospitalised for an acute asthma exacerbation. Moreover, we wish to investigate the characteristics of patients or therapy, if any, that would influence the magnitude of response attributable to the addition of anticholinergics.